Biotech Archives - Page 5 of 89 - Boston Life Sciences Times

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

April 28, 2026

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

April 27, 2026

908 Devices Names Kola Otitoju Chief Business & Strategy Officer, Announces Inducement Grant

April 22, 2026

THIS WEEK'S STORIES

Ironwood Pharmaceuticals to Present Data on Short Bowel Syndrome and GI Treatments at Digestive Disease Week 2026

April 23, 2026

LiquidCell Dx Names Mirna Jarosz CEO, Vincent A. Miller M.D. Senior Strategic Advisor

April 23, 2026

Prilenia Therapeutics Names Elisabeth Leiderman as Chief Financial Officer

April 28, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Biotech

VectorY Therapeutics Cleared to Expand ALS Clinical Trial to Europe and U.K.

Boston Cell Standards Advances Toward FDA Qualification for Cancer Testing Platform

Seaport Therapeutics Adds Biotech Leader Sharon Mates to Board

4Moving Biotech Secures FDA Fast Track Status for Experimental Knee Osteoarthritis Drug

PureTech Reports Promising Early Trial Results for Blood Cancer Therapy

Most Read

Chiesi Group to Acquire KalVista Pharmaceuticals in $1.9 Billion Deal

Strand Therapeutics Names Kunal Bhatia Chief Financial Officer

Convergent Therapeutics Appoints Andrew Davis as Chief Business and Strategy Officer

Axoft Raises $55 Million to Expand Brain-Computer Interface Trials and Manufacturing

EDITOR PICKS